Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU). [electronic resource]
Producer: 20190730Description: 379-385 p. digitalISSN:- 1651-2057
- Adolescent
- Adult
- Aged
- Antipruritics -- adverse effects
- Aprepitant -- adverse effects
- Cross-Over Studies
- Double-Blind Method
- Drug Resistance
- Female
- Germany
- Histamine Antagonists -- therapeutic use
- Humans
- Male
- Middle Aged
- Neurokinin-1 Receptor Antagonists -- adverse effects
- Prurigo -- diagnosis
- Quality of Life
- Severity of Illness Index
- Time Factors
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.